The traditional goal of isolating a single, perfect clone is misleading. Biology's inherent variability means even the first cell division introduces differences. A more effective approach is to assess a cell population's performance distribution (e.g., productivity, growth) to gauge its robustness and predictability over many generations.
Academic research often proves a concept once, sufficient for publication. However, creating a commercially viable technology requires extensive refinement to ensure it's consistent and repeatable across different users, labs, and equipment. This gap between a single success and a robust product is the "valley of death" for university spinouts.
Selling a novel deep-tech platform involves more than data. The path to the first contract requires securing proof-of-concept funding, actively seeking critical feedback beyond your friendly network, and ultimately leveraging long-term, trusted relationships to find a partner willing to take the initial risk—often incentivized by significant discounts.
Successful entrepreneurs view all customer feedback, positive or negative, as a valuable gift of data. This information shouldn't be taken personally but used strategically to refine the product, messaging, and even the company's core focus. This responsiveness is key to evolving and finding true product-market fit in a complex industry.